- In vitro growth suppresion of AML and CML progenitors by recombinant trail (APO2L)2000 | First Faculty of Medicine
- Growth suppression of CFU-GM progenitors by recombinant trail in MDS and myeloid leukemiasPublication without faculty affiliation
- The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials2021 | First Faculty of Medicine, Second Faculty of Medicine
- Resistance to TRAIL in mantle cell lymphoma cells is associated with the decreased expression of purine metabolism enzymes2013 | First Faculty of Medicine